| melanoma |
Nab vs Decarbazine |
NCT00864253 |
| operable breast |
Nab vs Paclitaxol based neoadjuvant chemotherpay |
NCT01583426 |
| operable breast |
Nab vs Paclitaxol based neoadjuvant chemo |
NCT01822314 |
| operable breast |
Nab+EC or AC vs Paclitaxel+EC or AC |
|
| elderly operable breast |
EC vs CMF vs Capcitabine+Nab-Paclitaxel |
NCT01204437 |
| recurrent or metastatic breast |
Bevacizumab+Pacliatxel vs Bev+ Nab-P vs Bev+ixabepalone |
NCT00785291 |
| metastatic breast |
Nab-Paclitaxel+Gem Carbo vs Gem Carbo |
NCT01881230 |
| advanced NSCLC |
Maintenance Nab-Paclitaxel following Nab-Pac+Carbo |
NCT02027428 |
| unresectable pancreatic |
Nab-paclitaxol+FOLFIRNIOX+Gemcitabine+Capcitabine ±Algenepantucel-L |
NCT01836432 |
| resected pancreatic |
Gem+Nab-Paclitaxel vs Gem |
NCT01964430 |
